Tanios S. Bekaii-Saab, MD, FACP; Eileen O’Reilly, MD; Thorvardur Halfdanarson, MD; Christopher Lieu, MD; Lorenza Rimassa, MD

Community Practice Connections™: 21st Annual Meeting of the International Society of Gastrointestinal Oncology

Biree Andemariam, MD; Wally R. Smith, MD; William T. Zempsky, MD

Medical Crossfire®: Optimal Approaches to Evaluating and Addressing Pain in the Patient With Sickle Cell Disease

Rounds with Dr Jabbour: Breaking Barriers in ALL Treatment

Diana V. Do, MD; Michael W. Stewart, MD; Paolo Lanzetta, MD; Dilraj Grewal, MD

Rapid Reviews in Retina™: Emerging Updates from Fall 2024 - Addressing the Wealth of New Data in Treatments for nAMD and DME

Burst CME™: Addressing Diagnostic Challenges and Identifying Targets for Treatment in LCNEC-L

Burst CME™: Exploring Diagnosis and Testing Innovations for Targetable Mutations in SCLC

Burst CME™: Advanced Diagnostic and Testing Approaches for Mutation-Targetable Management of NSCLC

Virginia Kaklamani, MD, DSc; William J Gradishar, MD, FASCO, FACP

Community Practice Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2- Breast Cancer

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

Aditya Bardia, MD, MPH; Heather McArthur, MD, MPH; Sonya Reid, MD, MPH

Medical Crossfire®: Improving Survival in HR-Positive HER2-Negative Metastatic Breast Cancer – Advances in Selective Estrogen Receptor Targeting Therapies

Mitch Ibach, OD, FAAO; Jessica Steen, OD, FAAO

(CME Track) Leveraging Rho Kinase Inhibition in Glaucoma Management — How Can Novel Treatment Pathways Impact Patient Outcomes?

(COPE Track) Leveraging Rho Kinase Inhibition in Glaucoma Management — How Can Novel Treatment Pathways Impact Patient Outcomes?

Catherine C. Coombs, MD, MS; Paolo Ghia, MD, PhD; Tycel J. Phillips, MD; Jeffrey V. Matous, MD; Grzegorz S. Nowakowski, MD, FASCO

Navigating the Next Wave in BTK Inhibition Strategies: Maximizing Clinical Benefit in CLL and MCL, What’s Next in B-Cell Malignancies

Craig Emmitt Cole, MD; Sikander Ailawadhi, MD; Irene Ghobrial, MD; Monique Hartley-Brown, MD, MMSc

Addressing Racial Disparities in Multiple Myeloma: Forging a Path Towards Health Equity in Clinical Trials and Everyday Practice

Sandra Quezada, MD, MS, AGAF; Oriana Damas, MD

Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care

Burst CME™: How is the Newly Approved CAR T-Cell Therapy Impacting R/R B-Cell ALL Management?

Jacqueline Theis, OD, FAAO; Cecelia Koetting, OD, FAAO, DipABO; Melissa Barnett, OD, FAAO, FSLS, FBCLA

(CME Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention

(COPE Track) Neurotrophic Keratitis in Focus – From Early Recognition to Strategic Intervention

Arshad M. Khanani, MD, MA, FASRS; Carl J. Danzig, MD, FASRS; Jennifer I. Lim, MD, FARVO

(COPE Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

Carrie M. Hersh, DO, MSc, FAAN; Anna Shah, MD

Medical Crossfire®: Integrating Real-World Data to Improve Outcomes for Patients With Multiple Sclerosis

Hope S. Rugo, MD, FASCO; Kevin Kalinsky, MD, MS; Joyce O’Shaughnessy, MD

Medical Crossfire: Next-Generation Endocrine Therapy for ER+/HER2- Breast Cancer: Addressing Unmet Needs and Keys to Optimization in Clinical Practice

18th Annual New York GU Cancers Congress™

James F. Howard Jr, MD; Nicholas J. Silvestri, MD, FAAN; Neelam Goyal, MD

Medical Crossfire® - Optimizing Management for Patients With Generalized Myasthenia Gravis: Focus on Complement Inhibitors

Kimberly Brown, MD; Chad Kodiak, RPh, PharmD; Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Collaborating Across the Continuum™: Identifying and Preventing Hepatic Encephalopathy in Long-Term Care Settings

Tina Bhutani, MD, MAS, FAAD; Jason E. Hawkes MD, MS

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

Charu Aggarwal, MD, MPH, FASCO; Christine Bestvina, MD; Hatim Husain, MD; Karen L. Reckamp, MD, MS

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

Charles P. Vega, MD; Stephen Brunton, MD, FAAFP, FRACGP, CDCES; Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP

Cases and Conversations: Evidence-Based Approaches to Management of CKD in Your Patients With T2DM

SimulatEd™: Patient-Centered Care to Improve Outcomes in Chronic Lymphocytic Leukemia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Beth Sandy, MSN, CRNP, FAPO; Laura Wood, RN, MSN, OCN; Michael Lai, ARNP; Tiffany Richards, PhD, ANP-BC, AOCNP®; Lauren Verity Moore, DNP, MSN, AGACNP-BC; Megan Wanca, APRN, DNP, FNP-C

Community Practice Connections™: 8th Annual School of Nursing Oncology™

David R. Gandara, MD; Roy S. Herbst, MD, PhD; Pasi Jänne, MD, PhD; Heather A. Wakelee, MD, FASCO

Community Practice Connections™: 25th Annual International Lung Cancer Congress

Matt Lunning DO, FACP; Kami Maddocks, MD; Grzegorz S. Nowakowski, MD, FASCO; Sarah C. Rutherford, MD

Contextualizing Advances in Relapse Refractory DLBCL: Navigating Biomarkers, Emerging Data, and Adverse Event Management to Transform Patient Care

Burst CME™: Tackling Adverse Events With Targeted Therapies for Diffuse B-Cell Lymphoma

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

John Brandsema, MD; Carla D. Zingariello, DO

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

Jeffrey A. Allen, MD; Karissa L. Gable, MD

Identifying and Treating CIDP in the Modern Era

Corey Cutler, MD, MPH, FRCPC; Amin M. Alousi, MD; Yi-Bin Chen, MD; Carrie Lynn Kitko, MD

Show Me the Data: How Do We Navigate the Latest Evidence on Novel Therapies and Trials Across GvHD Prophylaxis, Acute, and Chronic Care?

Naval G. Daver, MD; Jessica Altman, MD; Amir T. Fathi, MD; Gail J. Roboz, MD; Joshua Zeidner, MD

Medical Crossfire®: Bridging Evidence to Practice in AML…Updates on FLT3, IDH1/2, Maintenance, Combos, and Clinical Trials

C. Ola Landgren, MD, PhD; Cristina Gasparetto, MD; Katja Weisel, MD

How We Do It®: New Combinations Reshaping Treatment Decision-Making in Newly Diagnosed Multiple Myeloma

Alexey V. Danilov, MD, PhD; Leidy L. Isenalumhe, MD, MS; Lori A. Leslie, MD; Mazyar Shadman, MD, MPH; Jason R. Westin, MD, MS, FACP

Show Me the Data™: Pushing CAR Ts Forward Across Lymphoid Malignancies…Accelerating Access in the Community and the Treatment Strategies for the Road Ahead

Matt Lunning, DO, FACP; Sarah C. Rutherford, MD

Burst CME™: Biomarkers in Diffuse Large B-Cell Lymphoma: Empowering Treatment Decisions to Improve Outcomes

Jacob Sands, MD; Myung-Ju Ahn, MD; Aaron Lisberg, MD

What’s Next for HER2- and TROP2-Directed ADCs in Lung Cancer: How Emerging Trial Data will Impact our Clinics Today, and Tomorrow….

Anne Chiang, MD, PhD; Jonathan Wesley Riess, MD, MS; Misty D. Shields, MD, PhD

Do We Have Sea Change in Small Cell Lung Cancer? What Recent Clinical Trial Data Tell Us About Treatment Decision-Making in Real-World Settings, What’s Next for Emerging Novel Strategies

Rami S. Komrokji, MD; Ghaith Abu-Zeinah, MD; Gabriela Hobbs, MD; Barbara Mora, MD

Medical Crossfire®: Bridging Expert Guidance and Evidence-Based Recommendations in the Ever-Evolving Treatment of MF, PV, and ET

Elias Jabbour, MD; Hagop M. Kantarjian, MD; Aaron Logan, MD, PhD, MPhil; Rob Pieters, MD, PhD; Claire Roddie, MD, PhD

Medical Crossfire®: New Horizons in Acute Lymphoblastic Leukemia—How The Experts Apply New Evidence from AYA to Adult Scenarios

Krina Patel, MD, MSc; Alfred L. Garfall, MD; Ajay K. Nooka, MD, MPH, FACP

From Barriers to Breakthroughs in Multiple Myeloma: How Trials Compare to the Real-World Management of Patients in Your Practice

Deborah Ristvedt, DO; Melissa Tawa, OD, FAAO

(COPE Track) Burst CME™ Part 2: Interventional Glaucoma Treatment: Evolving Paradigms for Addressing Unmet Needs

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Anil K. Agarwal, MD; Nissreen Elfadawy MD, MSc, FASN

Expert Illustrations and Commentaries™: The Role of the Paracellular Pathway in the Management of Hyperphosphatemia in CKD

(CME Track) Burst CME™ Part 3: Initiating Early Intervention in Patients With Glaucoma Who Fail Pharmacological Therapy

Eytan M. Stein, MD; Marina Kremyanskaya, MD, PhD; Hannah Levavi, MD

Addressing Pivotal Updates in AML – Expert Perspectives on Individualizing Management for Special Populations

Daniel J. DeAngelo, MD, PhD; Claire Roddie, MD, PhD

Advances In™: Taking R/R B-Cell ALL Management to the Next Level With New CAR T Approval

(CME Credit) Community Practice Connections™: Applying Advances in Neovascular Retinal Disease - Expanding Treatment Intervals & Enhancing Outcomes

Innovations in MDS Care: Navigating New Treatment Paradigms, Breakthrough Therapies, and Emerging Clinical Evidence

The Expanding Role of Artificial Intelligence in Dentistry

Ajai Chari, MD; Adriana Rossi, MD; Anupama Kumar, MD


Medical Crossfire®: Uncovering The Clinical Utility of Combination Therapies and MRD Assessment in Newly Diagnosed Multiple Myeloma

Ghassan Abou-Alfa, MD, MBA; Richard Finn, MD; Sharlene Gill, MD, MPH, MBA, FRCP(C), FASCO; Masafumi Ikeda, MD, PhD


Community Practice Connections™: Individualizing Treatment Plans in Advanced Hepatocellular Carcinoma Based on Biology and Other Patient Characteristics

SimulatEd™ From Discomfort to Relief: Acute Pain Management Essentials

Matt Lunning, DO, FACP; Grzegorz S. Nowakowski, MD., FASCO

Burst CME™: Treating Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Current Options and Emerging Approaches

Sara A. Hurvitz, MD, FACP; Joyce O’Shaughnessy, MD; Heather McArthur, MD, MPH; Hope S. Rugo, MD, FASCO


  Community Practice Connections™: 23rd Annual International Congress on the Future of Breast Cancer West

Corey Cutler, MD, MPH, FRCP(C); Carrie L. Kitko, MD

BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatment in Chronic GVHD

Peter Robert Galle, MD, PhD; Amit Singal, MD, MS; Linda L. Wong, MD; Ghassan Abou-Alfa, MD, MBA; Han Chong Toh, MD 

Community Practice Connections™: 14th Asia-Pacific Primary Liver Cancer Expert Meeting

Tina Bhutani, MD, MAS, FAAD; Rajal Patel, MD

Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach

Veeral Sheth, MD, MBA, FACS, FASRS; Dante Pieramici, MD; Arshad Khanani, MD, MA, FASRS

Clinical Consultations™: Novel Therapeutic Targets in Neovascular Retinal Diseases – A Focus on the Roles of VEGF-C/D

EnVision Summit

Amrita Krishnan, MD; Suzanne Lentzsch, MD, PhD; Sagar Lonial, MD, FACP

New Horizons in Multiple Myeloma Treatment – Selection and Sequencing From Newly Diagnosed to Relapsed/Refractory Disease

David M. Brown, MD, FACS; David A. Eichenbaum, MD; Hong-Uyen Hua, MD; Prethy Rao, MD, MPH, FACS

Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease

Burst CME™ Part II: The Evolving Treatment Landscape for Huntington Disease

Ghassan Abou-Alfa, MD, MBA; Richard Finn, MD; Sharlene Gill, MD, MPH, MBA, FRCP(C), FASCO; Masafumi Ikeda, MD, PhD

Medical Crossfire: Individualizing Treatment Plans in Advanced Hepatocellular Carcinoma Based on Biology and Other Patient Characteristics

Peter Kaiser, MD; Laxmi V. Devisetty, MD; Priya Vakharia, MD; Adrienne W. Scott, MD, FASRS

Rapid Reviews in Retina™: Emerging Updates from Summer 2024 - Addressing the Wealth of New Data in Treatments for nAMD and DME

Katherine Talcott, MD; William Wagner, MD

SimulatED™: Pioneering Treat-and-Extend Therapy—The Impact of Early Application

Steven Flamm, MD, FAASLD, FACG; Marcelo Kugelmas, MD, FACP, FAASLD

Burst CME™: Future Implications for the Treatment Landscape of Primary Biliary Cholangitis (PBC)

Burst CME™: Reimagining Approaches to Treating Patients with Primary Biliary Cholangitis (PBC)

Burst CME™: Enhancing Strategies for Diagnosing Primary Biliary Cholangitis (PBC)

Sanjai Rao, MD, DFAPA; Jonathan M. Meyer, MD

Expert Illustrations & Commentaries™: New Targets for Treatment in Cognitive Impairment in Schizophrenia – The Role of NMDA Receptors and Co-agonists

Jason Hafron, MD; Aaron D. Berger, MD; Arpeet Shah, MD

Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment

Martin Pollak, MD; Opeyemi A. Olabisi, MD, PhD

Patient, Provider & Caregiver Connection™: Individualizing Care in Chronic Kidney Disease – Understanding Disparities in Care and the Role of APOL1 Mediated Kidney Disease

BURST CME™ Part I: Understanding the Impact of Huntington’s Disease

Barbara Pro, MD; Saad Usmani, MD, MBA, FACP, FASCO; Amer Zeidan, MBBS, MHS

8th Annual Live Medical Crossfire®: Hematologic Malignancies

Andrew Alexis, MD, MPH; Lakshi M. Aldredge, MSN, ANP-BC, DCNP

Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

BURST CME™: The Evolving Role of PD-1 Inhibition in Nasopharyngeal Carcinoma Management

Sarah C. Rutherford, MD; Matthew Lunning, DO, FACP

Community Practice Connections™: Selecting and Sequencing Therapy for Patients with DLBCL in an Era of Expanding Options

Amer Zeidan, MBBS, MHS; Michael R. Savona, MD

Community Practice Connections™: Exploring the Dynamic Shifts in the MDS Treatment Paradigm: Unveiling Advances in Disease Modifying Therapies, Spotlight on Cutting-Edge Clinical Trials, and the Latest Approvals

Jeneth Aquino, DNP, FNP-BC; Beth Sandy, MSN, CRNP, FAPO; Allison M. Walker, ACNP, MSN, MSW, BS

Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management

20th Annual New York Lung Cancers Symposium®

Stacy E. Croteau, MD, MMS; Fernando F. Corrales-Medina, MD, FAAP;

Patient, Provider, & Caregiver Connection: Individualizing Care in Hemophilia A to Optimize Joint Health and Prevent Synovitis

43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®

4th Annual International Congress on Pediatric Oncology

Pamela Ganschow, MD; Gautum Agarwal, MD; Folasade (Fola) P. May, MD, PhD, MPhil

Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care

Milan J. Anadkat, MD; Johann E. Gudjonsson MD, PhD; Robert G. Micheletti, MD

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

BURST CME™: Advancements in Targeted Therapies for Low-Grade Gliomas: Current Insights and Future Prospects

BURST CME™: Navigating Treatment Progression, Addressing Unmet Needs, and Evolution of Testing and Classification Approaches in Glioma

BURST CME™: Targeted Therapies for High-Grade Gliomas: Enhancing Treatment Strategies and Future Horizons

BURST CME™: Integrating Recent Advances into Contemporary Management Strategies in Pediatric Glioma

Advances In™: Moving Care Forward in SCLC with DLL3 Targeting Bispecific T-Cell Engagers

Dani Cabral, MD; Marwan N. Sabbagh, MD, FAAN, FANA

Continuing Education